Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 132 results:
[ Συντάκτης] Τίτλος Τύπος Έτος Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines..
Curr Mol Med. 9(3), 299-314.
(2009). Nonalcoholic fatty liver disease and Helicobacter pylori infection. Is it time to address this potential relationship?.
Curr Vasc Pharmacol.
(2023). Irisin: a renaissance in metabolism?.
Metabolism. 62(8), 1037-44.
(2013). Leptin in health and disease: facts and expectations at its twentieth anniversary..
Metabolism. 64(1), 5-12.
(2015). Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease..
J Bone Miner Metab. 28(6), 706-12.
(2010). Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD..
J Clin Endocrinol Metab.
(2019). The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease..
Diabetes Obes Metab. 12(5), 365-83.
(2010). Menopause and metabolic dysfunction-associated steatotic liver disease..
Maturitas. 108024.
(2024). Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016). Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial..
Diabetes Obes Metab. 19(12), 1805-1809.
(2017). Treatment of nonalcoholic fatty liver disease with an anti-osteoporotic medication: A hypothesis on drug repurposing..
Med Hypotheses. 110379.
(2020). Spironolactone revisited..
J Clin Hypertens (Greenwich). 13(10), 783-4.
(2011). Periostin and sclerostin levels in juvenile Paget's disease..
Clin Cases Miner Bone Metab. 14(2), 269-271.
(2017). Obesity: seize the day, fight the fat..
Metabolism. 92, 1-5.
(2019). Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease..
Hormones (Athens).
(2022). Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease..
Int J Food Sci Nutr. 63(6), 659-66.
(2012). Sarcopenic obesity..
Hormones (Athens). 17(3), 321-331.
(2018). Paget's disease of bone: emphasis on treatment with zoledronic acid..
Expert Rev Endocrinol Metab. 4(5), 423-434.
(2009). Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease..
Metabolism. 147, 155676.
(2023). Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease..
Metabolism. 63(2), 161-7.
(2014). An update on the validity of irisin assays and the link between irisin and hepatic metabolism..
Metabolism. 64(9), 937-42.
(2015). Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid..
Endokrynol Pol. 63(4), 312-5.
(2012). Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis..
Metabolism. 154203.
(2020). Systematic review of cases reporting blood extravasation-related complications after thyroid fine-needle biopsy..
J Otolaryngol Head Neck Surg. 39(5), 532-41.
(2010).
(2016).